Curaleaf Holdings, Inc.
CURLFOTCHealthcare● Active
$11.51
+$0.59(+5.40%)
Market Cap$3.0B
P/E Ratio—
52W High$11.51
52W Low$0.72
Curaleaf Holdings, Inc. (CURLF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CURLF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.09
Est. -$0.08 · +212.5%
Revenue
$0.32B
Est. $0.32B · +2.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 6-Quarter EPS Beat Streak
CURLF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | -$0.07 | — | — | — | $0.33B | — |
| ▲ Q2 FY2026 | May 5, 2026 | -$0.08 | $0.09 | +212.5% | $0.32B | $0.32B | +2.3% |
| ▲ Q1 FY2026 | Feb 26, 2026 | -$0.08 | -$0.05 | +37.5% | $0.33B | $0.33B | +0.9% |
| ▲ Q4 FY2025 | Nov 5, 2025 | -$0.07 | -$0.06 | +14.3% | $0.32B | $0.32B | +1.1% |
| ▲ Q3 FY2025 | Aug 6, 2025 | -$0.07 | -$0.06 | +14.3% | $0.32B | $0.31B | +0.3% |
| — Q2 FY2025 | May 8, 2025 | -$0.07 | -$0.07 | +0.0% | $0.31B | $0.31B | -0.6% |
| ▲ Q1 FY2025 | Mar 3, 2025 | -$0.06 | $0.02 | +133.3% | $0.33B | $0.33B | -0.3% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -$0.06 | -$0.07 | -16.7% | $0.33B | $0.34B | -3.7% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
-$0.07
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
$0.09
EPS Est.
-$0.08
EPS Surpr.
+212.5%
Revenue
$0.32B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
-$0.05
EPS Est.
-$0.08
EPS Surpr.
+37.5%
Revenue
$0.33B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
-$0.06
EPS Est.
-$0.07
EPS Surpr.
+14.3%
Revenue
$0.32B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
-$0.06
EPS Est.
-$0.07
EPS Surpr.
+14.3%
Revenue
$0.32B
Q2 FY2025
May 8, 2025
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
+0.0%
Revenue
$0.31B
Q1 FY2025
Mar 3, 2025Beat
EPS Actual
$0.02
EPS Est.
-$0.06
EPS Surpr.
+133.3%
Revenue
$0.33B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
-$0.07
EPS Est.
-$0.06
EPS Surpr.
-16.7%
Revenue
$0.33B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q3 FY2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q2 FY2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q1 FY2027 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Q4 FY2026 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Q3 FY2026 | $-0.07 | $-0.06 | $-0.04 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.4B | $0.4B | $0.4B | 3 |
| Q3 FY2027 | $0.4B | $0.4B | $0.4B | 3 |
| Q2 FY2027 | $0.4B | $0.4B | $0.4B | 3 |
| Q1 FY2027 | $0.3B | $0.4B | $0.4B | 3 |
| Q4 FY2026 | $0.3B | $0.3B | $0.4B | 5 |
| Q3 FY2026 | $0.3B | $0.3B | $0.3B | 6 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +212.5% | $9.78 | $10.44 | +6.75% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +37.5% | $7.44 | $7.29 | -2.02% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +14.3% | $8.01 | $8.55 | +6.74% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +14.3% | $5.70 | $5.04 | -11.58% |
| ▲ Q2 FY2025 | May 8, 2025 | +0.0% | $2.58 | $2.68 | +3.88% |
| ▲ Q1 FY2025 | Mar 3, 2025 | +133.3% | $3.93 | $3.51 | -10.69% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -16.7% | $9.36 | $6.51 | -30.45% |
| ▼ Q3 FY2024 | Aug 7, 2024 | -20.0% | $10.29 | $9.57 | -7.00% |
Q2 FY2026+6.75%
Report Date
May 5, 2026
EPS Beat/Miss
+212.5%
Price Before
$9.78
Price After
$10.44
Q1 FY2026-2.02%
Report Date
Feb 26, 2026
EPS Beat/Miss
+37.5%
Price Before
$7.44
Price After
$7.29
Q4 FY2025+6.74%
Report Date
Nov 5, 2025
EPS Beat/Miss
+14.3%
Price Before
$8.01
Price After
$8.55
Q3 FY2025-11.58%
Report Date
Aug 6, 2025
EPS Beat/Miss
+14.3%
Price Before
$5.70
Price After
$5.04
Q2 FY2025+3.88%
Report Date
May 8, 2025
EPS Beat/Miss
+0.0%
Price Before
$2.58
Price After
$2.68
Q1 FY2025-10.69%
Report Date
Mar 3, 2025
EPS Beat/Miss
+133.3%
Price Before
$3.93
Price After
$3.51
Q4 FY2024-30.45%
Report Date
Nov 6, 2024
EPS Beat/Miss
-16.7%
Price Before
$9.36
Price After
$6.51
Q3 FY2024-7.00%
Report Date
Aug 7, 2024
EPS Beat/Miss
-20.0%
Price Before
$10.29
Price After
$9.57
Avg Beat Reaction-1.15%
Avg Miss Reaction-18.73%
Beat Rate6 / 8 quarters
Largest Move-30.45% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CURLF ends December
Curaleaf Holdings, Inc. (CURLF) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.09 — beating the analyst consensus of $-0.08 by +212.5%. CURLF has beaten EPS estimates for 6 consecutive quarters. The next CURLF earnings date is expected around September 1, 2026.
Each quarter, investors track CURLF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CURLF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CURLF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CURLF earnings · 5 questionsCuraleaf Holdings, Inc.'s next earnings report is expected around September 1, 2026. CURLF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CURLF historically reports after market close (AMC).
CURLF earnings datewhen is CURLF earningsCURLF next earnings datewhen does CURLF report earningsCURLF earnings calendar
▸ Source: FMP · Curaleaf Holdings, Inc. SEC filings · US GAAP · Curaleaf Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026